Lyell Immunopharma, Inc. Current Ratio in % from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Lyell Immunopharma, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2025.
  • Lyell Immunopharma, Inc. Current Ratio for the quarter ending September 30, 2025 was 793 %, a 48.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Lyell Immunopharma, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 793 -760 -48.9% Sep 30, 2025
Q2 2025 859 -779 -47.6% Jun 30, 2025
Q1 2025 1.03K -646 -38.6% Mar 31, 2025
Q4 2024 1.24K -522 -29.7% Dec 31, 2024
Q3 2024 1.55K -245 -13.6% Sep 30, 2024
Q2 2024 1.64K -18.7 -1.13% Jun 30, 2024
Q1 2024 1.67K +137 +8.93% Mar 31, 2024
Q4 2023 1.76K +311 +21.4% Dec 31, 2023
Q3 2023 1.8K +436 +32% Sep 30, 2023
Q2 2023 1.66K +365 +28.2% Jun 30, 2023
Q1 2023 1.54K +247 +19.2% Mar 31, 2023
Q4 2022 1.45K Dec 31, 2022
Q3 2022 1.36K Sep 30, 2022
Q2 2022 1.29K Jun 30, 2022
Q1 2022 1.29K Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.